Delivery of asthma medication with pressurized metered-dose inhalers is economical, effective, and convenient. This method of delivery is a critical part of the medical management program for most ...
The global metered dose inhalers (MDI) market is poised for significant growth, with an estimated market size of USD 26,322.9 million in 2023, up from USD 25,208.9 million in 2022. According to a ...
The propellants used in metered-dose inhalers (MDIs) have always contributed significantly to greenhouse gas emissions. Although the 1990s saw a switch from MDIs using ozone-depleting ...
Pressurised metered dose inhalers (pMDI) delivering drugs for asthma, chronic obstructive pulmonary disease and other respiratory diseases currently use hydrofluorocarbon (HFC) propellants that ...
Honeywell Solstice® Air can cut metered dose inhaler greenhouse gas emissions of up to 99.9% versus current propellants1 CHARLOTTE, N.C., October, 2024 – Honeywell (NASDAQ: HON) today announced a long ...
Pharmaceutical companies are looking to change that with lower-emitting inhalers that they plan to roll out by the end of the decade. Metered-dose inhalers – pressurized devices that release a ...